IRIS
MAZZUCCHELLI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.946
AS - Asia 5.871
EU - Europa 5.805
SA - Sud America 1.423
AF - Africa 285
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 15
AN - Antartide 1
Totale 25.367
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.684
SG - Singapore 1.797
VN - Vietnam 1.168
BR - Brasile 1.130
RU - Federazione Russa 1.059
UA - Ucraina 1.018
CN - Cina 842
DE - Germania 611
HK - Hong Kong 583
IE - Irlanda 569
TR - Turchia 554
IT - Italia 528
SE - Svezia 521
DK - Danimarca 387
FR - Francia 375
FI - Finlandia 310
KR - Corea 223
GB - Regno Unito 222
IN - India 152
CA - Canada 135
AR - Argentina 98
MX - Messico 97
CI - Costa d'Avorio 89
BD - Bangladesh 81
IQ - Iraq 73
ID - Indonesia 63
ZA - Sudafrica 58
EC - Ecuador 57
JP - Giappone 55
MA - Marocco 41
PK - Pakistan 39
CO - Colombia 37
BE - Belgio 31
PL - Polonia 31
NL - Olanda 29
SA - Arabia Saudita 27
VE - Venezuela 27
ES - Italia 26
UZ - Uzbekistan 25
IR - Iran 24
EG - Egitto 22
PH - Filippine 21
MY - Malesia 20
PE - Perù 20
RO - Romania 20
CL - Cile 19
PY - Paraguay 18
EU - Europa 17
JO - Giordania 17
TH - Thailandia 16
AT - Austria 14
DZ - Algeria 14
KE - Kenya 14
TW - Taiwan 14
KZ - Kazakistan 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
AU - Australia 9
UY - Uruguay 9
ET - Etiopia 8
AL - Albania 7
AZ - Azerbaigian 7
CH - Svizzera 7
GR - Grecia 7
LB - Libano 7
OM - Oman 7
BH - Bahrain 6
KG - Kirghizistan 6
NP - Nepal 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
BO - Bolivia 5
CR - Costa Rica 5
NG - Nigeria 5
PA - Panama 5
AO - Angola 4
CZ - Repubblica Ceca 4
HN - Honduras 4
HU - Ungheria 4
RS - Serbia 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
JM - Giamaica 3
LT - Lituania 3
PS - Palestinian Territory 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
CG - Congo 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GD - Grenada 2
GT - Guatemala 2
GY - Guiana 2
MM - Myanmar 2
MU - Mauritius 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
AQ - Antartide 1
BB - Barbados 1
Totale 25.339
Salva come PNG Salva come JPEG
Città #
Ashburn 1.693
Singapore 1.183
Jacksonville 1.027
Chandler 976
Fairfield 758
Dallas 697
Des Moines 580
Boardman 568
Dublin 568
Hong Kong 556
San Jose 407
Wilmington 401
Ho Chi Minh City 389
New York 367
Woodbridge 330
Houston 280
Seattle 275
Hanoi 252
The Dalles 234
Lawrence 224
Princeton 224
San Mateo 215
Beijing 213
Lauterbourg 210
Cambridge 207
Ann Arbor 192
Moscow 154
Centro 135
Hefei 134
Los Angeles 125
São Paulo 97
San Diego 92
Abidjan 89
Munich 87
Helsinki 73
Buffalo 67
Haiphong 65
Chicago 64
Da Nang 60
London 51
Council Bluffs 49
Vancouver 48
Tokyo 44
Redmond 42
Turku 39
Mexico City 36
Santa Clara 36
Shanghai 36
Frankfurt am Main 35
Baghdad 34
Rio de Janeiro 34
Orem 33
Brussels 31
Guangzhou 31
Washington 31
Wuhan 30
Milan 28
Pune 28
Warsaw 28
Belo Horizonte 27
Chennai 27
Ancona 26
Marche 24
Biên Hòa 23
Denver 22
Tashkent 22
Brooklyn 21
Izmir 21
Rome 21
Manchester 20
Montreal 20
Turin 20
Atlanta 19
Hải Dương 19
Columbus 18
Curitiba 18
Erbil 18
Guayaquil 18
Durban 17
Istanbul 17
Porto 17
Quito 17
Salvador 17
Johannesburg 16
Phoenix 16
Stockholm 16
Amman 15
Brasília 14
Campinas 14
Norwalk 14
Porto Alegre 14
Salt Lake City 14
San Francisco 14
Elk Grove Village 13
Jiaxing 13
Toronto 13
Amsterdam 12
Brasov 12
Fortaleza 12
Jeddah 12
Totale 15.715
Salva come PNG Salva come JPEG
Nome #
Cellular Modulators of the NRF2/KEAP1 Signaling Pathway in Prostate Cancer 416
Metabolic phenotype of bladder cancer 251
Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. 213
The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer 197
AT-rich interactive domain 1A protein expression in normal and pathological pregnancies complicated by preeclampsia 192
Predicting future cancer burden in the United States by artificial neural networks 187
Clinical progression of megacalycosis in a girl with a solitary kidney: The lesson learned 184
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. 177
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications 176
Ciliary neurotrophic factor (CNTF) and its receptor (CNTFRα) signal through MAPK/ERK pathway in human prostate tissues: a morphological and biomolecular study 173
"Pathological" reflection on European urology: extended, saturation, and systematic prostate biopsies. 172
Chromosomal Abnormalities in Macroscopically Normal Urothelium in Patiens with Bladder pT1 and pT2a Urothelial Carcinoma: a Fluorescence in situ hybridisation Study and Correlation with Histologic Features. 166
Secondary neoplasms of the urinary system and male genital organs. 165
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy 159
HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected andreogen-dependent and androgen-independent cancer. 156
2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections 155
alpha-methylacyl-CoA racemase (P504S)/34 beta E12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy 153
[Interstitial cystitis: minimal diagnostic criteria]. 153
Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. 152
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 152
Atypical foci, suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy") 151
Active surveillance for low-risk prostate cancer. 150
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View 149
Metabolic Alterations in Renal and Prostate Cancer 148
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry 147
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer. 144
Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. 144
Adipose cannabinoid CB1 receptor expression and adiponectin correlate with microvascular damage in human kidney 144
[Thin glomerular basement membrane disease]. 143
ANCA-Associated Glomerulonephritis and Anti-Phospholipid Syndrome in a Patient with SARS-CoV-2 Infection: Just a Coincidence? 143
Effect of complete androgen blockade on pathologic stage and resection margin status of prostate cancer: Progress pathology report of the Italian PROSIT study 140
Angiogenesis as prognostic factor in small renal tumors 140
Low HtrA1 expression in patients with long‑standing ulcerative colitis and colorectal cancer 140
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review 140
Analytical and Qualitative Cytology and Histology. Reflection on the past two years. 139
2005 update on pathology of prostate biopsies with cancer 139
Genitourinary cancers: molecular determinants for personalized therapies 139
Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network. 138
AT-rich interactive domain 1A (ARID1A) cannot be considered a morphological marker for prostate cancer progression: A pilot study 137
Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma. 136
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 136
Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis 136
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians 135
A contemporary update on pathology reporting for urinary bladder cancer. 133
[Nephrotic proteinuria with type 2 diabetes mellitus and autoimmune thyroiditis]. 131
Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT 129
Expression of pi-class glutathione S-transferase: two populations of high grade prostatic intraepithelial neoplasia with different relations to carcinoma 129
A painful diagnosis 129
Urothelial papillary lesions. Development of a Bayesian Belief Network for diagnosis and grading 128
Epigenetic modifications and modulators in prostate cancer 128
Morphological diagnosis of urothelial neoplasms. 127
Adipose cannabinoid CBI receptor and adiponectin expression correlate with microvascular damage in human-kidney 127
Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View 127
Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur. 127
Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test. 126
PUNLMP or not PUNLMP? This is the problem. 125
Increased VEGF165 expression in HCT116 colon cancer cells after transient transfection with a GFP vector encoding HIF-1 gene. 125
Prognostic role of Furhman grade and vascular endothelia growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens 124
Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies. 124
HtrA1 in human urothelial bladder cancer: a secreted protein and a potential novel biomarker. 124
Pseudocarcinomatous hyperplasia associated with primary lymphoma in the urinary bladder: a case report 124
Narrative review of prostate cancer grading systems: Will the Gleason scores be replaced by the grade groups? 124
Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in Renal Cell Carcinoma 123
Biphasic Tumors of the Urogenital Tract: Selected Topics 122
pT1 high-grade bladder cancer: histologic criteria, pitfalls in the assessment of invasion, and substaging 121
Morphological assessment of radical prostatectomy specimens. A protocol with clinical relevance. 120
Changes in the normal-looking epithelium in prostates with PIN or cancer. 119
Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstruction. 118
alpha-Methylacyl coenzyme A racemase, Ki-67, and topoisomerase IIalpha in cystoprostatectomies with incidental prostate cancer 118
Re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738–9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides 118
Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma 118
Joint appraisal of the radical prostatectomy specimen by the urologist and the uropathologist: together, we can do it better 117
Pathology and molecular updates in tumors of the prostate: towards a personalized approach. 116
Ciliary Neurotrophic Factor Modulates Multiple Downstream Signaling Pathways in Prostate Cancer Inhibiting Cell Invasiveness 116
Gleason grading of prostate carcinoma in needle biopsies vs. radical prostatectomy specimens. 115
A magnetic resonance imaging-based nomogram for predicting clinically significant prostate cancer at radical prostatectomy 114
Renal sarcoma associated with adult polycystic kidney disease. A case report and literature review. 114
Immunohistochemical expression of Endothelin-1 and Endothelin-A and Endothelin-B receptors in high-grade prostatic intraepithelial neoplasia and prostate cancer. 114
Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer. 114
Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer. 113
Urothelial changes induced by therapeutic procedures for bladder cancer. A review. 112
Case diagnosis as positive identification in prostatic neoplasia 112
KIDNEY CANCER: NOT A SINGLE DISEASE. 111
Recurrent papillary urothelial neoplasm of low malignant potential. Subtle architectural disorder detected by quantitative analysis in DAXX-immunostained tissue sections. 111
Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapy. 111
Pathology of prostate cancer and focal therapy ('male lumpectomy'). 110
Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder. 110
Extent of cancer of less than 50% in any prostate needle biopsy core: how many millimeters are there? 110
Pathological definition and difficulties in assessing positive margins in radical prostatectomy specimens. 108
Prostate carcinoma I: prognostic factors in radical prostatectomy specimens and pelvic lymph nodes 108
Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients 108
Prostate cancer in 2021: Novelties in prognostic and therapeutic biomarker evaluation 108
Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer? 107
Molecular mechanisms in prostate cancer. A review. 107
Molecular techniques and prostate cancer diagnostic. 107
Primary carcinoid tumor of the Kidney: a case report and review of the literature. 107
Apolipoprotein E expression in localized prostate cancers. 106
Specimen orientation by marking the peripheral end: (potential) clinical advantages in prostate biopsy. 106
Evaluation of prognostic factors in radical prostatectomy specimens with cancer 106
Somatostatin receptor subtypes in hormone-refractory (castration-resistant) prostatic carcinoma. 106
Totale 13.699
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.395
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.395
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021675 0 0 0 0 0 0 0 0 0 263 297 115
2021/20221.661 117 392 55 93 11 109 47 108 106 132 107 384
2022/20233.227 282 248 202 277 224 840 8 202 738 17 125 64
2023/20241.857 312 56 90 268 317 427 26 41 13 44 31 232
2024/20253.689 389 311 190 89 116 109 350 176 925 257 352 425
2025/20268.871 530 704 752 1.023 855 663 1.824 955 805 760 0 0
Totale 25.628